As of July 27, 2024, Innova Captab, Listed Shares are trading at ₹610.00 per share.
ISIN
INE0DUT01020
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
₹ 10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Share
4,80,00,000
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
P/E
****
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
Market Capitalisation
₹ 2,928 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Enterprise Value
₹ ****
It measures companys total value, which includes market capitalization, debt and excludes cash.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Listed
Category is defined as a class or division of things regarded as having particular shared characteristics.
Innova Captab Growth
Compounded Sales Growth
Highlights
About Company - Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution, marketing, and exports. The business includes a contract development and manufacturing organization (“CDMO”) business providing manufacturing services to Indian pharmaceutical companies, a domestic branded generics business, and an international branded generics business.
Top CDMO Player - Innova Captab is ranked the 2nd largest Contract Development and Manufacturing Organization (CDMO) for formulations in India, serving 10 of the top 10 and 14 of the top 15 Indian pharma companies.
Key Clients - Some of our key customers include Cipla Limited, Glenmark Pharmaceuticals, Wockhardt Limited, Corona Remedies, Emcure Pharmaceuticals, Lupin Limited, Intas Pharmaceuticals, Leeford Healthcare, Medley Pharmaceuticals, Cachet Pharmaceuticals, Eris Healthcare, Indoco Remedies, J. B. Chemicals and Pharmaceuticals, Oaknet Healthcare, Zuventus Healthcare, Ajanta Pharma, Mankind Pharma and Smart Laboratories.